Since entering China in 2003, NEA has invested close to $400 million in a portfolio of over 20 promising companies. In 2009 these companies generated more than $2.3 billion in annual sales and created more than 17,000 jobs in China. From the largest Chinese semiconductor foundry, to the first U.S. FDA certified cGMP facility in China for pharmaceutical production, to the leading B2C E-commerce company serving middle class consumers, many of our companies are leading their respective industries to transform how people live, work and play in China and around the world.
Among the first U.S. venture firms to begin investing in China, NEA has built an extensive network of relationships and a strong deal flow. With a localized team of professionals on the ground in Shanghai and Beijing, we have taken a different approach to growth investing, beginning with a forward-looking assessment of fundamental secular trends. Whether you are running a burgeoning start-up or an emerging category leader, we look to partner with extraordinary entrepreneurs to build transformational businesses in technology, consumer and healthcare.